Janet Lau

Statistics

Publications

Citations

490

H-Index

Active since

2013

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Janet Lau is an author at Genomics Institute of the Novartis Research Foundation specializing in oncology, medicine, and type 1 diabetes pathophysiology.

Publications per year

2013–2023

Publications

Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice

Janet Lau, Jeanne Cheung, Armando Navarro et al. · Nature Communications · 2017 · 364 citations · Full text

Medicine, Immunology, Oncology +17

Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform

Andrew H. Ko, Kyu‐pyo Kim, Jens T. Siveke et al. · The Oncologist · 2023 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Synthesis and Evaluation of Camptothecin Antibody–Drug Conjugates

Wěi Li, Karen Veale, Qifeng Qiu et al. · ACS Medicinal Chemistry Letters · 2019 · 44 citations · Full text

Pharmacy, Oncology, Pharmacology +17

IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes

Yaiza Diaz-de-Durana, Janet Lau, Deborah Knee et al. · PLoS ONE · 2013 · 16 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice

Janet Lau, Qiang Zhou, Susan Sutton et al. · PLoS ONE · 2014 · 10 citations · Full text

Medicine, Molecular Biology, Pharmacology +13

1–5 of 5